Biomerica submits application for PLA code for inFoods IBS diagnostic test

Biomerica (BMRA) announced that the Company and its CLIA laboratory partner have submitted an application to the American Medical Association CPT Editorial Panel requesting the assignment of a Proprietary Laboratory Analysis, PLA, code for the inFoods IBS diagnostic test. If granted, the PLA code will provide a test-specific code to submit claims to Medicare and other insurers. The PLA code would represent a next step on the pathway to expand patient access to the inFoods IBS product, a personalized test and therapy for treating Irritable Bowel Syndrome. Strategic Milestone to Expand Patient Access: The PLA code application supports Biomerica’s commercialization strategy to facilitate access to the inFoods IBS test. The establishment of a PLA code for inFoods IBS will allow for transparency in claims submission and adjudication for inFoods IBS